» Articles » PMID: 23839040

Rapamycin Regulates Biochemical Metabolites

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2013 Jul 11
PMID 23839040
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth, and deregulation of this pathway is associated with tumorigenesis. p53, and its less investigated family member p73, have been shown to interact closely with mTOR pathways through the transcriptional regulation of different target genes. To investigate the metabolic changes that occur upon inhibition of the mTOR pathway and the role of p73 in this response primary mouse embryonic fibroblast from control and TAp73(-/-) were treated with the macrocyclic lactone rapamycin. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analysis were used to obtain a rapamycin-dependent global metabolome profile from control or TAp73(-/-) cells. In total 289 metabolites involved in selective pathways were identified; 39 biochemical metabolites were found to be significantly altered, many of which are known to be associated with the cellular stress response.

Citing Articles

The uniformity and stability of cellular mass density in mammalian cell culture.

Liu X, Oh S, Kirschner M Front Cell Dev Biol. 2022; 10:1017499.

PMID: 36313562 PMC: 9597509. DOI: 10.3389/fcell.2022.1017499.


A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo.

Ma Y, Zhu Q, Liang J, Li Y, Li M, Zhang Y Signal Transduct Target Ther. 2020; 5(1):152.

PMID: 32811807 PMC: 7434905. DOI: 10.1038/s41392-020-0203-1.


Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism.

Guo L, Worth A, Mesaros C, Snyder N, Glickson J, Blair I Rapid Commun Mass Spectrom. 2016; 30(16):1835-45.

PMID: 27476658 PMC: 4970762. DOI: 10.1002/rcm.7667.


p63 supports aerobic respiration through hexokinase II.

Viticchie G, Agostini M, Lena A, Mancini M, Zhou H, Zolla L Proc Natl Acad Sci U S A. 2015; 112(37):11577-82.

PMID: 26324887 PMC: 4577137. DOI: 10.1073/pnas.1508871112.


Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays.

Knight R, Gostev M, Ilisavskii S, Willis A, Melino G, Antonov A Oncotarget. 2014; 5(3):659-66.

PMID: 24553133 PMC: 3996666. DOI: 10.18632/oncotarget.1597.


References
1.
Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G . The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene. 2009; 28(35):3157-66. PMC: 3865854. DOI: 10.1038/onc.2009.177. View

2.
Wang J, Liu Y, Hande M, Wong A, Jin Y, Yin Y . TAp73 is a downstream target of p53 in controlling the cellular defense against stress. J Biol Chem. 2007; 282(40):29152-62. DOI: 10.1074/jbc.M703408200. View

3.
Melino G . p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ. 2011; 18(9):1487-99. PMC: 3178431. DOI: 10.1038/cdd.2011.81. View

4.
Newbold A, Vervoort S, Martin B, Bots M, Johnstone R . Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors. Cell Death Dis. 2012; 3:e387. PMC: 3461364. DOI: 10.1038/cddis.2012.128. View

5.
Rufini A, Tucci P, Celardo I, Melino G . Senescence and aging: the critical roles of p53. Oncogene. 2013; 32(43):5129-43. DOI: 10.1038/onc.2012.640. View